OwieClear Atrial Fibrillation (AFib) Page Accuracy Review
An accuracy review of the OwieClear atrial fibrillation page, finding the core messages correct but the page thin, and asking for symptom reranking, stroke risk framing, classification, anticoagulation detail, rate versus rhythm control, and triggers.
Submitted research brief - Submitted to OwieClear; written with an AI assistant - November 2026
Read this first. This document was written outside OwieClear and has not been reviewed by a clinician. We publish it so you can read the source for yourself. It is educational and is not medical advice. Where our own pages disagree with it, follow our pages, which cite their sources, and ask a healthcare professional about anything that affects your care.
What we found that needs correcting
- The review's overall judgment is correct and we accept it: the page was directionally right and far too thin for a condition this common with stroke consequences this serious. Every numbered gap it raises has been addressed, and the page has been largely rebuilt.
- On the first and highest-priority point, symptom ranking. The review is right that fatigue and shortness of breath were wrongly listed as less common. They are among the most frequent complaints, and fatigue is often the symptom that persists between episodes. Both have been moved to the common list, along with reduced exercise tolerance and lightheadedness.
- The review's suggested line that many people have no symptoms at all now opens the symptom section rather than appearing as a footnote. This is the single most consequential fact about AFib for a general reader, because feeling well is routinely taken as evidence of low risk, and it is not.
- On the second point, stroke risk stratification. The page now explains that the decision is made from risk factors rather than symptoms, names what those factors are, says that clinicians use a score, and states plainly that anticoagulants should never be started or stopped on your own. A full deep dive covers how the score is used and what the bleeding trade-off actually is.
- On the third point, types of AFib. Paroxysmal, persistent and permanent are now defined in the overview, with the clarification the review did not ask for but which we think matters: the type describes the pattern of episodes, not the stroke risk, and paroxysmal AFib is not a low-risk category.
- On the fourth point, anticoagulation options. DOACs are now named as first-line for most people, with warfarin identified as the right choice for mechanical valves and some mitral valve disease. We have also added what the review did not request and we consider a safety gap: that missing doses of a DOAC leaves a real window of reduced protection within about a day, and that pausing one for dental work or surgery must go through the prescriber.
- On the fifth point, rate versus rhythm control. Both strategies are now described with their usual drug classes, and the page states that rate control slows the pulse without ending the fibrillation, which is why stroke prevention continues regardless. A separate deep dive covers cardioversion and ablation, including the 48-hour clot precaution before cardioversion.
- On the sixth point, triggers and lifestyle. Alcohol, sleep apnea, obesity, thyroid disease and endurance training are now covered, with the weight the evidence supports: alcohol reduction has randomized trial evidence behind it and is listed first. We have departed from the review on caffeine, which it does not raise: moderate intake has not been shown to trigger AFib in most studies, and we say so rather than repeating the common advice to give up coffee.
- On the seventh point, the heart failure link. The page now says the two conditions commonly coexist and worsen each other, and adds that a persistently fast rate can itself weaken the heart muscle, which is often reversible.
- The suggested urgent-care framing has been adopted. Stroke signs, chest pain, severe breathlessness and fainting are 911. A sustained very rapid rate is same-day, as are a first episode and an episode lasting beyond about 24 to 48 hours.
- Three additions of our own. A section on bleeding precautions and head injury, because people on anticoagulants are not routinely told that a knock on the head needs assessment even when they feel fine. A note that heart rate monitors and fitness trackers are unreliable during AFib, which causes needless alarm. And a page on anxiety, because living with an unpredictable heartbeat has a psychological cost that is consistently under-discussed and is treatable.
- We have also added sixteen research deep dives covering what AFib is, the classification, the electrical mechanism from pulmonary vein trigger to irregular pulse, the causes and triggers, why clots form in the left atrial appendage, diagnosis and monitoring including smartwatches, the clinical presentation, the three jobs of treatment, anticoagulation in detail, cardioversion and ablation, daily life, trigger tracking, anxiety and emergency planning, prevention, coexisting conditions, and how AFib treatment was worked out.
Download the PDF
Our reviewed pages on this
All source documents